Skip to content
AnalystLens

METLIFE INC 8-K Report, Financial Obligation (Sep 30, 2024)

Reports
Financial Events·Other Events·Exhibits & Filings
Filing Date
Filed September 30, 2024
Period End
September 26, 2024
In the record · 2016–202610-K1110-Q328-K249

MET filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 249 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Jun ’22Jun ’22
  3. Leadership change8-K · Feb ’26Feb ’26

Summary

Summary of the 8-K filed September 30, 2024. Cited figures are marked; the original filing is the authoritative source.

MetLife Inc. (MET) filed an 8-K on September 29, 2024, detailing the issuance of an additional $250 milliona in 5.300% Senior Notes due 2034.

This issuance, which occurred on September 30, 2024, was conducted under the Company's existing shelf registration statement and supplements a prior issuance of the same notes. The primary purpose of this filing is to report a new direct financial obligation. Investors should note that this $250 millionb debt issuance increases the Company's overall leverage.

The fixed interest rate of 5.300%c on these notes will contribute to ongoing interest expenses. The full terms and conditions of these notes and the related indentures are incorporated by reference into this filing.

Key Highlights

  1. MetLife Inc. issued an additional $250 million in 5.300% Senior Notes due 2034 on September 30, 2024.
  2. This issuance is a direct financial obligation of the Company.
  3. The new notes were issued under the Company's existing shelf registration statement (File No. 333-268442).
  4. This additional debt issuance supplements a prior offering of the same 5.300% Senior Notes due 2034.
  5. The filing includes details on the underwriting and pricing agreements with major financial institutions.
  6. Legal opinions regarding the validity of the New Senior Notes are included as exhibits.

Frequently Asked Questions

  1. What is the main purpose of this 8-K filing?

    The main purpose of this 8-K filing is to report the creation of a direct financial obligation by MetLife Inc., specifically the issuance of an additional $250 million in 5.300% Senior Notes due 2034.

  2. How does this debt issuance affect MetLife's financial position?

    This issuance increases MetLife's total debt by $250 million and will contribute to its ongoing interest expenses at a rate of 5.300% annually on the principal amount of these new notes. This impacts the company's leverage ratios.

  3. Were these notes issued at a discount or premium?

    The filing does not explicitly state whether the notes were issued at a discount or premium; it reports the aggregate principal amount of $250,000,000. The pricing agreement (Exhibit 1.2) would contain this information, but it is not detailed in the provided 8-K text.

  4. Where can I find more detailed information about these Senior Notes?

    More detailed information can be found in the referenced exhibits, including the Forty-Seventh Supplemental Indenture (Exhibit 4.3) and the Form of Senior Note (Exhibit 4.4), as well as the underwriting and pricing agreements. The underlying Senior Indenture (Exhibit 4.1) and the Forty-Sixth Supplemental Indenture (Exhibit 4.2) also provide context.